# Delovabiotech

**Canonical:** https://apis.io/providers/delovabiotech/  
**Website:** https://delovabio.com  
**APIs profiled:** 1

Delovabiotech (南京清普生物科技有限公司) is a China‑based biotechnology company focused on developing non‑opioid, long‑acting pain management drugs. It aims to improve human health by innovating scientifically, offering products such as the patented long‑acting NSAID injection ‘普坦宁®’ and the newly approved oral formulation ‘美洛昔康注射液（II）’. The firm has a robust pipeline with over 10 projects, multiple IND filings, and has secured significant C‑round financing to accelerate clinical translation and commercialization.

## Kin Score — 10.2 / 100 (minimal)

Scored 2026-10-23 under rubric 0.25.0.

| Facet | Score |
|---|---|
| Discoverability | 53.6 |
| Contract Quality | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 31.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Horizontal (data, software, accessibility, platform)**: 5.9 (matched via fallback).

## Agent readiness — 3.1 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | documented |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |
| Pagination Ratio | na |
| Operation Distinctiveness | na |

## APIs (1)

- **Delovabiotech API** — API reference for Delovabiotech services

## Security (1)

- **Delovabiotech Domain Security** — TLSv1.2 · HSTS

## Tags

Company, Biotechnology, Pain Management, China, Non-Opioid

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/delovabiotech/). Scores are computed from the provider's own public artifacts under a published rubric.